Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Incidentie en overleving van maligne extracraniële kiemceltumoren in Nederland: 1990-2018
mei 2024